Health / Pharma

Cancer and Clinical Trials: The Role of Big Data In Personalizing the Health Experience

13th Sep `13, 01:47 PM in Health / Pharma

Despite considerable progress in prevention and treatment, cancer remains the second leading cause of death in the United…

BDMS
Guest Contributor
 

Despite considerable progress in prevention and treatment, cancer remains the second leading cause of death in the United States. Even with the $50 billion pharmaceutical companies spend on research and development every year, any given cancer drug is ineffective in 75% of the patients receiving it. Typically, oncologists start patients on the cheapest likely chemotherapy (or the one their formulary suggests first) and in the 75% likelihood of non-response, iterate with increasingly expensive drugs until they find one that works, or until the patient dies. This process is inefficient and expensive, and subjects patients to unnecessary side effects, as well as causing them to lose precious time in their fight against a progressive disease. The vision is to enable oncologists to prescribe the right chemical the first time–one that will kill the target cancer cells with the least collateral damage to the patient.

Read More
MORE FROM BIG DATA MADE SIMPLE